These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 21723252)
41. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine. Peng XX; Shi Z; Damaraju VL; Huang XC; Kruh GD; Wu HC; Zhou Y; Tiwari A; Fu L; Cass CE; Chen ZS Leuk Res; 2008 May; 32(5):799-809. PubMed ID: 17996297 [TBL] [Abstract][Full Text] [Related]
42. The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Adamson PC; Poplack DG; Balis FM Leuk Res; 1994 Nov; 18(11):805-10. PubMed ID: 7967706 [TBL] [Abstract][Full Text] [Related]
43. The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs. Coulthard SA; Hogarth LA; Little M; Matheson EC; Redfern CP; Minto L; Hall AG Mol Pharmacol; 2002 Jul; 62(1):102-9. PubMed ID: 12065760 [TBL] [Abstract][Full Text] [Related]
44. 6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs. Lee NY; Sai Y; Nakashima E; Ohtsuki S; Kang YS J Pharm Sci; 2011 Sep; 100(9):3773-82. PubMed ID: 21590775 [TBL] [Abstract][Full Text] [Related]
45. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Evensen NA; Madhusoodhan PP; Meyer J; Saliba J; Chowdhury A; Araten DJ; Nersting J; Bhatla T; Vincent TL; Teachey D; Hunger SP; Yang J; Schmiegelow K; Carroll WL Haematologica; 2018 May; 103(5):830-839. PubMed ID: 29449434 [TBL] [Abstract][Full Text] [Related]
46. Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites. Elgemeie GH Curr Pharm Des; 2003; 9(31):2627-42. PubMed ID: 14529546 [TBL] [Abstract][Full Text] [Related]
47. Formation of 6-thioguanine and 6-mercaptopurine from their 9-alkyl derivatives in mice. Nelson JA; Vidale E Cancer Res; 1986 Jan; 46(1):137-40. PubMed ID: 3940185 [TBL] [Abstract][Full Text] [Related]
48. Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells. Adamson PC; Balis FM; Hawkins ME; Murphy RF; Poplack DG Biochem Pharmacol; 1993 Nov; 46(9):1627-36. PubMed ID: 8240420 [TBL] [Abstract][Full Text] [Related]
49. Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination. Tedeschi PM; Kathari YK; Johnson-Farley N; Bertino JR Cancer Chemother Pharmacol; 2015 Jun; 75(6):1247-52. PubMed ID: 25917288 [TBL] [Abstract][Full Text] [Related]
50. Mutations at serine 37 in mouse guanylate kinase confer resistance to 6-thioguanine. Ardiani A; Goyke A; Black ME Protein Eng Des Sel; 2009 Apr; 22(4):225-32. PubMed ID: 19136674 [TBL] [Abstract][Full Text] [Related]
51. Drug-gene modeling in pediatric T-cell acute lymphoblastic leukemia highlights importance of 6-mercaptopurine for outcome. Beesley AH; Firth MJ; Anderson D; Samuels AL; Ford J; Kees UR Cancer Res; 2013 May; 73(9):2749-59. PubMed ID: 23436797 [TBL] [Abstract][Full Text] [Related]
52. Ecto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity. Li F; Fridley BL; Matimba A; Kalari KR; Pelleymounter L; Moon I; Ji Y; Jenkins GD; Batzler A; Wang L; Weinshilboum RM Drug Metab Dispos; 2010 Dec; 38(12):2329-38. PubMed ID: 20855458 [TBL] [Abstract][Full Text] [Related]
53. Apoptosome activation, an important molecular instigator in 6-mercaptopurine induced Leydig cell death. Morgan JA; Lynch J; Panetta JC; Wang Y; Frase S; Bao J; Zheng J; Opferman JT; Janke L; Green DM; Chemaitilly W; Schuetz JD Sci Rep; 2015 Nov; 5():16488. PubMed ID: 26576726 [TBL] [Abstract][Full Text] [Related]
54. Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells. Panetta JC; Evans WE; Cheok MH Br J Cancer; 2006 Jan; 94(1):93-100. PubMed ID: 16333308 [TBL] [Abstract][Full Text] [Related]
55. Metabolic effects of thiopurine derivatives against human CCRF-CEM leukaemia cells. Shi RZ; Lyons SD; Christopherson RI Int J Biochem Cell Biol; 1998 Aug; 30(8):885-95. PubMed ID: 9744080 [TBL] [Abstract][Full Text] [Related]
56. Oxidation-mediated DNA cross-linking contributes to the toxicity of 6-thioguanine in human cells. Brem R; Karran P Cancer Res; 2012 Sep; 72(18):4787-95. PubMed ID: 22822082 [TBL] [Abstract][Full Text] [Related]
57. 6-mercaptopurine promotes energetic failure in proliferating T cells. Fernández-Ramos AA; Marchetti-Laurent C; Poindessous V; Antonio S; Laurent-Puig P; Bortoli S; Loriot MA; Pallet N Oncotarget; 2017 Jun; 8(26):43048-43060. PubMed ID: 28574837 [TBL] [Abstract][Full Text] [Related]
58. 6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1. Yuan B; Zhang J; Wang H; Xiong L; Cai Q; Wang T; Jacobsen S; Pradhan S; Wang Y Cancer Res; 2011 Mar; 71(5):1904-11. PubMed ID: 21239472 [TBL] [Abstract][Full Text] [Related]
59. Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia. Dieck CL; Tzoneva G; Forouhar F; Carpenter Z; Ambesi-Impiombato A; Sánchez-Martín M; Kirschner-Schwabe R; Lew S; Seetharaman J; Tong L; Ferrando AA Cancer Cell; 2018 Jul; 34(1):136-147.e6. PubMed ID: 29990496 [TBL] [Abstract][Full Text] [Related]
60. PKCζ and PKMζ are overexpressed in TCF3-rearranged paediatric acute lymphoblastic leukaemia and are associated with increased thiopurine sensitivity. Hartsink-Segers SA; Beaudoin JJ; Luijendijk MW; Exalto C; Pieters R; Den Boer ML Leukemia; 2015 Feb; 29(2):304-11. PubMed ID: 24990612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]